Field safety notices: Medtrade Products Ltd.
Manufacturer registered in EUDAMED: SRN GB-MF-000007864 ; country: United Kingdom
4 authority publications by 4 authorities, from 20 Oct 2025 to 13 Nov 2025.
Latest notice: 13 Nov 2025, AEMPS, Taponamiento hemostático uterino CELOX PPH. Modelo: FG08838281. UDI-DI: 15060206631486
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Medtrade Products Ltd. or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
2 distinct corrective actions.
Corrective action: 2 publications by AEMPS, MHRA, from 20 Oct 2025 to 13 Nov 2025
- Taponamiento hemostático uterino CELOX PPH. Modelo: FG08838281. UDI-DI: 15060206631486
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026
- MHRAUnited Kingdomofficial source: CELOX PPH, MHRA, 2025-10-20CELOX PPHModels, lots, UDI: FG08838281, FG08838171, FG08838291 and FG08838321
Source: MHRA, Field Safety Notices, gov.uk (Open Government Licence v3.0) Contains public sector information licensed under the Open Government Licence v3.0. · collected 17 Nov 2026
Corrective action: 2 publications by ANSM, IGJ, from 28 Oct 2025 to 10 Nov 2025
- Celox PPH
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Medtrade Products Ltd, FSN 2025-001, CELOX PPH
Bron: Inspectie Gezondheidszorg en Jeugd (IGJ), veiligheidswaarschuwingen (CC0) · collected 17 Nov 2026